The neuronal repellent SLIT2 is a target for repression by EZH2 in prostate cancer.
about
A transcriptional repressor co-regulatory network governing androgen response in prostate cancersTargeting EZH2 in cancerMyo9b is a key player in SLIT/ROBO-mediated lung tumor suppressionRole of CTCF in Regulating SLC45A3-ELK4 Chimeric RNA.Slits affect the timely migration of neural crest cells via Robo receptorInfluence of oncogenic transcription factors on chromatin conformation and implications in prostate cancer.Functional and therapeutic significance of EZH2 in urological cancersTGF-β mediated DNA methylation in prostate cancer.Regulation and Role of EZH2 in CancerGlucocorticoid regulation of SLIT/ROBO tumour suppressor genes in the ovarian surface epithelium and ovarian cancer cells.Interrogating genomic and epigenomic data to understand prostate cancerThe role of EZH2 in the regulation of the activity of matrix metalloproteinases in prostate cancer cells.EZH2-Mediated H3K27me3 Is Involved in Epigenetic Repression of Deleted in Liver Cancer 1 in Human CancersUSP33 mediates Slit-Robo signaling in inhibiting colorectal cancer cell migration.Coordinated regulation of polycomb group complexes through microRNAs in cancer.3-Deazaneplanocin A (DZNep), an inhibitor of the histone methyltransferase EZH2, induces apoptosis and reduces cell migration in chondrosarcoma cells.Epigenetics in prostate cancer.Silencing of Kruppel-like factor 2 by the histone methyltransferase EZH2 in human cancer.Honokiol inhibits bladder tumor growth by suppressing EZH2/miR-143 axis.Quantitative Histone Mass Spectrometry Identifies Elevated Histone H3 Lysine 27 (Lys27) Trimethylation in Melanoma.Multifaceted role of EZH2 in breast and prostate tumorigenesis: epigenetics and beyond.FOXA1 potentiates lineage-specific enhancer activation through modulating TET1 expression and function.Integrated bioinformatics analysis of chromatin regulator EZH2 in regulating mRNA and lncRNA expression by ChIP sequencing and RNA sequencing.A roundabout way to cancer.Emerging biomarkers of prostate cancer (Review)EZH2, an epigenetic driver of prostate cancer.Immunohistochemical staining of slit2 in primary and metastatic prostatic adenocarcinoma.CCN3/NOV gene expression in human prostate cancer is directly suppressed by the androgen receptor.Association between EZH2 expression, silencing of tumor suppressors and disease outcome in solid tumors.Mutations and deletions of PRC2 in prostate cancer.Feedback circuitry between miR-218 repression and RTK activation in glioblastoma.RUNX1, an androgen- and EZH2-regulated gene, has differential roles in AR-dependent and -independent prostate cancerEZH2 regulates cancer cell migration through repressing TIMP-3 in non-small cell lung cancer.Histone methyltransferase NSD2/MMSET mediates constitutive NF-κB signaling for cancer cell proliferation, survival, and tumor growth via a feed-forward loop.Cooperation between Polycomb and androgen receptor during oncogenic transformation.lncRNA HOTAIR Contributes to 5FU Resistance through Suppressing miR-218 and Activating NF-κB/TS Signaling in Colorectal Cancer.Isolation and characterization of a new naturally immortalized human breast carcinoma cell line, KAIMRC1.The Antisense Transcript SMN-AS1 Regulates SMN Expression and Is a Novel Therapeutic Target for Spinal Muscular Atrophy.Screen for Slit/Robo signaling in trunk neural cells reveals new players.Frequent SLIT2 promoter methylation in the serum of patients with ovarian cancer.
P2860
Q24317244-F7191333-9A9C-4535-8B17-D6BACCFB5D79Q26769027-ADD989C7-A654-49D4-A0D0-211C0EE2388FQ28117738-419C4C33-6504-4732-8B08-BAEB28DC68A3Q30277220-2C1B1FB0-D8B3-4F08-8CEC-752807C40E0AQ30539089-65003430-7282-4A51-BD66-F5EA82820F03Q33675577-5CD52E7A-51CF-4C68-88EA-ACED0E93F036Q33914244-8021D0D5-FA68-46A8-B6D1-9EB03CCA924BQ34039935-1E2908B2-1A5A-4493-B380-8FA6969630AEQ34043370-1AD0BCC5-6E95-4B58-9AD4-CCF3DD6DA0FBQ34087872-BB40019C-6E8F-48F5-8B22-8D5D4B13F822Q34125866-CD86EECC-34AD-4ADB-9818-7BAA2D6714A5Q34137728-9C6CEB5F-4C6C-45F6-B7AB-F636FD27BFF1Q34797908-1F0E6847-6994-476C-B3A1-737D9F6A59E8Q35070268-19316969-06F5-48F8-8402-64E60E2683EAQ35167450-3871072F-0993-4A4E-B880-B3E9D09E33F3Q35172602-AF511AFF-0215-404D-85DA-AF23D3ACD309Q35608952-4D83348C-27F4-47FA-904A-20E534725BBBQ35886877-FC899F6C-A6C4-4390-B678-B1FE3B31A1E9Q36545734-95D04908-CB50-43AE-B077-3B69B5618D91Q36745120-867C9A7E-CD25-4795-BEC4-469E4CD45692Q37089496-916D12F2-1D10-46BA-B8C4-ED510C3C8833Q37294790-6576DB87-29DD-43C4-BA6C-99182D9CDC74Q37697207-2D222E91-7A19-4C13-AF81-95ED75B6ED99Q38010295-9E2C27B3-56EE-4E71-A172-C256ECDA6912Q38013967-05D80EE4-A64F-4ED4-BE51-F6C2CEA40563Q38103472-396C6448-63DC-4A1E-931C-670C739E3F29Q38263430-2B41F47E-448F-4904-9B24-073FB6511501Q38318542-FB0AACA7-BDF4-4C37-ABDC-C7EF205C8A6CQ38758038-2BF3D67B-96F6-4F66-9681-07AFE6E35678Q38783694-D21DEA10-10F2-4DD4-B7C5-99A5987145A9Q38878830-99041362-9B76-4283-AA0C-FFB771F7C92AQ38925687-E43FEED7-BCF5-45D0-B377-56683D421D28Q39077650-9555BAAC-C003-4983-A820-69BFD71AA4D3Q39340075-D46358AB-53A7-4490-8714-26721F28836AQ39425976-20A1C5C4-6FF9-4B0B-B4DC-96D52586D1DEQ41191235-871A6175-799B-4971-A8C7-B8E0C7488E98Q47145171-0D0AC601-E9BF-4833-875D-766BC57C398DQ48382639-3ED77A46-48EE-4DA5-8720-7D2D113A18B1Q50086271-72652B8A-1943-470D-A3D0-6978DA70E3F3Q54309038-9791282F-807A-4BB9-B384-DBF450290734
P2860
The neuronal repellent SLIT2 is a target for repression by EZH2 in prostate cancer.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
The neuronal repellent SLIT2 is a target for repression by EZH2 in prostate cancer.
@en
The neuronal repellent SLIT2 is a target for repression by EZH2 in prostate cancer.
@nl
type
label
The neuronal repellent SLIT2 is a target for repression by EZH2 in prostate cancer.
@en
The neuronal repellent SLIT2 is a target for repression by EZH2 in prostate cancer.
@nl
prefLabel
The neuronal repellent SLIT2 is a target for repression by EZH2 in prostate cancer.
@en
The neuronal repellent SLIT2 is a target for repression by EZH2 in prostate cancer.
@nl
P2093
P2860
P50
P356
P1433
P1476
The neuronal repellent SLIT2 is a target for repression by EZH2 in prostate cancer.
@en
P2093
A M Chinnaiyan
R J Lonigro
P2860
P2888
P304
P356
10.1038/ONC.2010.269
P407
P577
2010-07-12T00:00:00Z
P5875
P6179
1039150703